Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in TNXP — Tonix Pharmaceuticals Holding Corp.

CIK 19617 NEW YORK, NY
Back to TNXP Full portfolio

Position in TNXP

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$77,975
+$2,020 QoQ
Shares Held
6,111
+10.6% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 103 holders
Holding Since
Sep 2020
20 quarters on record
Voting authority Sole 1% Shared 0% None 99%

Common Shares in TNXP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,196,194 across 425 Biotechnology names. TNXP ranks #282 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in TNXP

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $77,975 6,111
2026-03-31 $75,955 5,524
2025-12-31 $72,913 4,668
2025-09-30 $97,001 4,015
2025-06-30 $128,664 3,576
2024-12-31 $5,701 17,278
2024-09-30 $0 2
2024-06-30 $5 9
2024-03-31 $25 132
2023-09-30 $11,366 20,667
2023-06-30 $51,926 32,865
2023-03-31 $172,891 293,036
2022-12-31 $19,365 49,656
2022-09-30 $1,182 2,233
2022-06-30 $207 132
2022-03-31 $65,623 285,321
2021-12-31 $75,018 208,386
2021-09-30 $173,203 288,673
2021-06-30 $139,218 125,422
2020-09-30 $30,660 36,500